LU81799A1 - Solution stable d'erythromycine - Google Patents

Solution stable d'erythromycine Download PDF

Info

Publication number
LU81799A1
LU81799A1 LU81799A LU81799A LU81799A1 LU 81799 A1 LU81799 A1 LU 81799A1 LU 81799 A LU81799 A LU 81799A LU 81799 A LU81799 A LU 81799A LU 81799 A1 LU81799 A1 LU 81799A1
Authority
LU
Luxembourg
Prior art keywords
erythromycin
pharmaceutical composition
ethanol
acid
per
Prior art date
Application number
LU81799A
Other languages
English (en)
French (fr)
Inventor
J Chavers
H Takruri
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU81799A1 publication Critical patent/LU81799A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU81799A 1978-10-20 1979-10-18 Solution stable d'erythromycine LU81799A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95315978A 1978-10-20 1978-10-20
US95315978 1978-10-20

Publications (1)

Publication Number Publication Date
LU81799A1 true LU81799A1 (fr) 1980-01-25

Family

ID=25493654

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81799A LU81799A1 (fr) 1978-10-20 1979-10-18 Solution stable d'erythromycine

Country Status (13)

Country Link
EP (1) EP0010437B1 (de)
JP (1) JPS5557519A (de)
AU (1) AU529422B2 (de)
BE (1) BE879471A (de)
CA (1) CA1129772A (de)
CH (1) CH642544A5 (de)
DE (1) DE2967163D1 (de)
FR (1) FR2439016A1 (de)
GB (1) GB2031728B (de)
IE (1) IE49086B1 (de)
LU (1) LU81799A1 (de)
NZ (1) NZ191847A (de)
ZA (1) ZA795492B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
AU592629B2 (en) * 1986-01-31 1990-01-18 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes and their uses
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンｅ１含有の軟膏剤
DE19549794B4 (de) * 1994-10-26 2009-07-30 Novartis Ag Pharmazeutische Zusammensetzungen
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
EP1374855A1 (de) * 2001-03-30 2004-01-02 Takeda Chemical Industries, Ltd. Medizinische lösungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000263A (en) * 1975-05-02 1976-12-28 Westwood Pharmaceuticals, Inc. Erythromycin solution
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne

Also Published As

Publication number Publication date
AU529422B2 (en) 1983-06-09
ZA795492B (en) 1981-05-27
JPS5557519A (en) 1980-04-28
BE879471A (fr) 1980-04-18
GB2031728A (en) 1980-04-30
EP0010437A3 (en) 1981-05-13
IE791995L (en) 1980-04-20
JPH0157097B2 (de) 1989-12-04
NZ191847A (en) 1982-05-31
FR2439016B1 (de) 1983-05-27
CA1129772A (en) 1982-08-17
FR2439016A1 (fr) 1980-05-16
CH642544A5 (fr) 1984-04-30
EP0010437A2 (de) 1980-04-30
EP0010437B1 (de) 1984-08-08
IE49086B1 (en) 1985-07-24
DE2967163D1 (en) 1984-09-13
GB2031728B (en) 1983-02-16
AU5179079A (en) 1980-04-24

Similar Documents

Publication Publication Date Title
JP6936893B2 (ja) Ｓｇｌｔ−２阻害剤含む液体医薬組成物
FI101677B (fi) Menetelmä vedettömän transdermaalisen koostumuksen valmistamiseksi
EP0287488B1 (de) Arzneimittel, diätetisches Produkt und hygienisches Produkt in Form einer pulverigen Zusammensetzung, erhalten durch Adsorption der Wirkstoffe auf einem schnellöslichen Zucker und Verfahren zur Herstellung dieser Zusammensetzung
EP1937276B1 (de) Verbessertes testosterongel und anwendungsverfahren dafür
KR950008305B1 (ko) 2상 용매 담체 조성물
US8900634B2 (en) Diethylstilbestrol dosage form and methods of treatment using thereof
LU81799A1 (fr) Solution stable d'erythromycine
DE4244090A1 (en) Deactivating agent for active oxygen - is amino-thiosulphonic acid cpd. useful in treatment of, e.g. lung or cardiovascular disorders, or diabetes
JPS6321648B2 (de)
DE2218147C2 (de) Pharmazeutische Zubereitung
DE69903436T2 (de) Polyionische hydrogele auf der basis von chitosan und xanthangummi zur stabilisierung und kontrollierter freisetzung von vitaminen
EP2156832A1 (de) Pharmazeutische zusammensetzung
US6177413B1 (en) Stabilized aspirin compositions and method of preparation for oral and topical use
AU4104900A (en) Iodine preparation compositon
EP1729778B1 (de) Pharmazeutische zubereitung zur applikation auf die haut mit einem gehalt an drospirenon
EP0043548B1 (de) Salz aus Furosemid oder Piretanid als Säurekomponente und Penbutolol als Basenkomponente sowie Arzneimittel, das beide Komponenten enthält
JP2003505415A (ja) 皮膚、粘膜、器官または組織の疾患を治療するためのトシルクロルアミドの使用
FR2614203A1 (fr) Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation.
EP1622587B1 (de) Feste pharmazeutische zubereitung enthaltend levothyroxin- und/oder liothyroninsalze
JPS59219218A (ja) 局所用作用持続組成物
Somade et al. Effect of edible camphor administrations on levels of steroid and thyroid hormones in male wistar rats
JPH09176014A (ja) 抗真菌性外用組成物
LU86573A1 (de) Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen
RU2823711C2 (ru) Фармацевтические композиции луликоназола для местного применения
JPH08259465A (ja) 皮膚疾患治療用外用剤